Uranium Royalty Corp. (NASDAQ:UROY) Receives $4.12 Consensus PT from Analysts

Uranium Royalty Corp. (NASDAQ:UROY) has been given a consensus rating of “Moderate Buy” by the five brokerages that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $4.1250.

Several research firms have commented on UROY. HC Wainwright reaffirmed a “buy” rating and set a $4.50 price objective on shares of Uranium Royalty in a research note on Thursday, July 16th. Weiss Ratings downgraded Uranium Royalty from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 17th. Zacks Research cut Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Finally, National Bank Financial assumed coverage on Uranium Royalty in a report on Wednesday, July 29th. They set an “outperform” rating and a $3.75 price target for the company.

Uranium Royalty Stock Down 7.0%

Shares of Uranium Royalty stock opened at $4.24 on Thursday. The firm’s fifty day simple moving average is $3.86 and its 200-day simple moving average is $3.59. Uranium Royalty has a 12 month low of $2.56 and a 12 month high of $5.52. The company has a quick ratio of 0.87, a current ratio of 0.88 and a debt-to-equity ratio of 0.49.

Uranium Royalty (NASDAQ:UROY) last issued its quarterly earnings results on Monday, September 14th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.05. Uranium Royalty had a net margin of 25.88% and a return on equity of 10.86%. The firm had revenue of $51.68 million during the quarter, compared to analysts’ expectations of $52.23 million. As a group, analysts anticipate that Uranium Royalty will post 0.05 earnings per share for the current year.

Institutional Trading of Uranium Royalty

Several hedge funds have recently made changes to their positions in the company. CenterBook Partners LP lifted its position in Uranium Royalty by 828.7% in the fourth quarter. CenterBook Partners LP now owns 4,447,408 shares of the company’s stock valued at $15,744,000 after purchasing an additional 3,968,521 shares during the period. Banque Cantonale Vaudoise increased its position in Uranium Royalty by 9.7% during the 1st quarter. Banque Cantonale Vaudoise now owns 272,026 shares of the company’s stock worth $994,000 after purchasing an additional 24,000 shares during the period. Renaissance Technologies LLC increased its position in Uranium Royalty by 206.5% during the 1st quarter. Renaissance Technologies LLC now owns 196,751 shares of the company’s stock worth $718,000 after purchasing an additional 132,551 shares during the period. Quantbot Technologies LP purchased a new position in shares of Uranium Royalty during the 2nd quarter worth approximately $421,000. Finally, The Manufacturers Life Insurance Company raised its stake in shares of Uranium Royalty by 189.0% during the 1st quarter. The Manufacturers Life Insurance Company now owns 149,821 shares of the company’s stock worth $547,000 after buying an additional 97,977 shares in the last quarter. Institutional investors and hedge funds own 24.19% of the company’s stock.

About Uranium Royalty

Uranium Royalty Corp. is a uranium-focused royalty and streaming company. Rather than primarily mining uranium itself, the company seeks exposure to uranium prices and production by acquiring royalties, streams, offtake agreements, debt investments and equity interests related to uranium projects.

The company’s portfolio includes interests in uranium development, exploration and production assets, as well as physical uranium holdings. Its strategy is designed to provide diversified participation in the uranium sector while limiting the direct operating and capital requirements associated with developing and running mines.

Uranium Royalty Corp.